Resonancia magnética de dos pacientes con miocardiopatía dilatada. A la izquierda, paciente con fibrosis sin canales de conducción y a la derecha, paciente con múltiples canales.
    Investigación, Publicaciones
    Circulation: A study led by Spanish scientists identifies dilated cardiomyopathy patients at greater risk of sudden death and arrhythmias[

    The findings could help more precisely identify candidates for a preventive implantable defibrillator

    Dr. Pablo García-Pavía,
    Sobre el CNIC, Investigación
    Nature Medicine: Study establishes the role of new treatments for transthyretin amyloid cardiomyopathy

    The research demonstrates the benefit of a new gene silencer for treating the disease

    Pablo García Pavía y Nerea Mora.
    Investigación, Publicaciones
    Circulation: Largest genetic and MRI study carried out to date rules out the existence of heart disease

    Left ventricular hypertrabeculation, an anatomical feature of the heart traditionally linked to higher risk, does not worsen outcomes in patients with dilated cardiomyopathy

    Dr. Pablo García-Pavía junto con la Dra. Noelia Mora y la Dra. Belén Peiró
    Investigación, Publicaciones
    CNIC scientists identify a biomarker that improves risk prediction in a severe form of heart failure

    The biomarker MR-proADM improves risk prediction in patients with transthyretin amyloid cardiomyopathy (ATTR-CM) and is associated with greater disease severity, mortality, and heart failure events.

    •  
    • 1 de 3